Block Copolymer Immunoassay Reagents for Background Signal Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current diagnostic immunoassay compositions face challenges such as matrix effects, unspecific reactions, and significant background signals, which affect sensitivity, stability, accuracy, and reproducibility, particularly in point-of-care tests that require fast and automated processes.

Innovation Solution

A composition comprising Tris buffer compound, sodium chloride, and one or more block copolymers, which can be used as a buffer, diluent, or washing solution in immunoassays to minimize background signals and improve stability and reproducibility, optimized for use in point-of-care systems.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If current compositions are used in immunoassays, then the assay can be conducted, but background signals are significant and sensitivity is reduced

Engineering Contradiction:
ImprovesensitivityVSAvoidbackground signals
Core Design Contradiction:
Measurement precisionVSObject-generated harmful factors

Solution Approach 1:

The patent introduces block copolymers as intermediary substances in the assay composition. These copolymers act as mediators that interact with the matrix components and unspecific reactants, preventing them from generating background signals while allowing the specific analyte-antibody interactions to proceed. The block copolymer structure with hydrophobic and hydrophilic blocks enables it to sequester interfering substances, thereby improving sensitivity by reducing background noise.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent modifies the chemical composition parameters of the assay buffer by incorporating specific block copolymers at optimized concentrations. This parameter change transforms the composition from a standard buffer to an enhanced formulation that actively suppresses background signals. The addition of chaotropic agents and specific buffer components changes the physical-chemical parameters of the solution, creating an environment where unspecific reactions are minimized while maintaining assay functionality.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If traditional compositions are used, then the assay procedure is simple, but stability and reproducibility are poor

Engineering Contradiction:
ImprovereproducibilityVSAvoidcomposition complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent creates a composite assay composition by combining multiple components: block copolymers, chaotropic agents, buffer compounds, and surfactants. This composite formulation integrates substances with different functions - the block copolymers provide structural organization and interfere with unspecific binding, chaotropic agents denature proteins to prevent aggregation, buffers maintain pH stability, and surfactants reduce surface tension. The synergistic interaction of these composite components achieves improved reproducibility and stability that cannot be obtained with single-component formulations.

Inventive Principle:
Principle #40Composite materials

3Loss of time

If point-of-care systems are designed with fast processing, then test time is reduced, but matrix effects and unspecific reactions increase

Engineering Contradiction:
Improvetest timeVSAvoidmatrix effects
Core Design Contradiction:
Loss of timeVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary action by incorporating block copolymers and chaotropic agents into the assay composition before the test is performed. These pre-added substances are ready to immediately counteract matrix effects and unspecific reactions as soon as the sample is introduced. The block copolymers are pre-positioned to interact with matrix components, and chaotropic agents are pre-dissolved to rapidly denature interfering proteins. This preliminary preparation eliminates the need for additional processing steps, maintaining fast test times while preventing harmful effects.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS20240353398A1Diagnostic assay reagents comprising block co-polymers
Publication Date: 2024.10.24 OLSER DIAGNOSTICS LTD
  • US20240353398A1 patent drawing
  • US20240353398A1 patent drawing
  • US20240353398A1 patent drawing

AI summary

The present invention relates to compositions suitable for use in immunoassays and method of conducting immunoassays using compositions of the invention. The present invention relates to compositions comprising block co-polymers and/or chaotropic agents which are useful as buffer, diluent and/or washing solutions in immunoassays and immunoassay methods.